GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Other Long-Term Liabilities

Apollomics (Apollomics) Other Long-Term Liabilities : $0.33 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Apollomics Other Long-Term Liabilities?

Apollomics's other long-term liabilities for the quarter that ended in Dec. 2023 was $0.33 Mil.

Apollomics's quarterly other long-term liabilities declined from Dec. 2022 ($511.86 Mil) to Jun. 2023 ($1.25 Mil) and declined from Jun. 2023 ($1.25 Mil) to Dec. 2023 ($0.33 Mil).

Apollomics's annual other long-term liabilities increased from Dec. 2021 ($322.22 Mil) to Dec. 2022 ($511.86 Mil) but then declined from Dec. 2022 ($511.86 Mil) to Dec. 2023 ($0.33 Mil).

Apollomics Other Long-Term Liabilities Historical Data

The historical data trend for Apollomics's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollomics Other Long-Term Liabilities Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
- - - -

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Long-Term Liabilities Get a 7-Day Free Trial - - - - -

Apollomics Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Apollomics Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Apollomics's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollomics (Apollomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Other Long-Term Liabilities
Comparable Companies
ATHA STTK ACXP CARA TLSA ORMP IMMX CCCC GTHX GBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
APLM:USA
Address
989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Website
https://www.apollomicsinc.com
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.